{
    "clinical_study": {
        "@rank": "141250", 
        "arm_group": {
            "arm_group_label": "remifentanil", 
            "arm_group_type": "Experimental", 
            "description": "LMA removal was accomplished when remifentanil was maintained a predetermined concentration throughout the emergence periods."
        }, 
        "brief_summary": {
            "textblock": "The investigators attempted to determine the optimal effect-site concentration of\n      remifentanil for smooth removal of the LMA from propofol anesthesia."
        }, 
        "brief_title": "Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA)", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Drug Usage", 
        "detailed_description": {
            "textblock": "At the end of the surgery, propofol infusion was stopped and remifentanil was titrated to\n      predetermined (initial concentration 1.0 ng/ml for the first patient). LMA removal was\n      performed when the patients opened their eyes and spontaneous respiration and adequate tidal\n      volume and ventilatory frequency were confirmed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASA I-II patients undergoing general anesthesia for short elective surgery (<1 hr)\n\n        Exclusion Criteria:\n\n          -  G-E reflux\n\n          -  obesity (BMI>30)\n\n          -  anticipated difficult airway"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01931683", 
            "org_study_id": "AJIRB-MED-CT4-13"
        }, 
        "intervention": [
            {
                "arm_group_label": "remifentanil", 
                "description": "The concentration of remifentanil was determined by modified Dixon's up-and-down method, starting from 1.0 ng/ml (0.2 ng/ml as a step size)", 
                "intervention_name": "remifentanil", 
                "intervention_type": "Drug", 
                "other_name": "Ultiva"
            }, 
            {
                "arm_group_label": "remifentanil", 
                "description": "LMA was removed when the patients opened their eyes, and spontaneous respiration and adequate tidal volume and ventilatory frequency were confirmed", 
                "intervention_name": "laryngeal mask airway (LMA)", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Remifentanil"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "LMA removal", 
            "remifentanil", 
            "propofol"
        ], 
        "lastchanged_date": "August 28, 2013", 
        "location": {
            "contact": {
                "email": "kjyeop@ajou.ac.kr", 
                "last_name": "Jong Yeop Kim, MD", 
                "phone": "82-31-219-5574"
            }, 
            "facility": {
                "address": {
                    "city": "Suwon", 
                    "country": "Korea, Republic of", 
                    "zip": "443-721"
                }, 
                "name": "Ajou University School of Medicine"
            }, 
            "investigator": {
                "last_name": "Han Bum Joe, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effect-site Concentration of Remifentanil for Smooth Removal of the LMA From Propofol Anesthesia", 
        "overall_contact": {
            "email": "kjyeop@ajou.ac.kr", 
            "last_name": "Jong Yeop Kim, MD", 
            "phone": "82-31-219-5574"
        }, 
        "overall_contact_backup": {
            "email": "joehanbum@naver.com", 
            "last_name": "Han Bum Joe, MD", 
            "phone": "82-31-219-4916"
        }, 
        "overall_official": {
            "affiliation": "Ajou University School of Medicine", 
            "last_name": "Jong Yeop Kim, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "the response of patients to the removal of LMA (classified as either 'success [smooth emergence]' or 'failure') during infusion of remifentanil.", 
            "measure": "smooth removal of LMA", 
            "safety_issue": "Yes", 
            "time_frame": "from end of surgery to removal of LMA (participants will be followed for the emergence periods, an expected average of 15 min)."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01931683"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ajou University School of Medicine", 
            "investigator_full_name": "Jong Yeop Kim", 
            "investigator_title": "Associate professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ajou University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ajou University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}